Early identification of diseases is essential for improving patient outcomes and reducing the impact of chronic conditions. Traditionally, disease screening has relied on symptomatic observations and conventional diagnostic tests. However, these approaches often fail to pinpoint diseases in their preclinical stages, when intervention is significant